Skip to main content

Eli Lilly misses on earnings but raises full-year guidance

The company reported adjusted earnings of $1.62, which missed analyst expectations of $1.73 for the quarter.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.